New drug duo slashes bad cholesterol in high-risk patients by nearly 49%
New Atlas - 18-May-2025Combo of ezetimibe and obicetrapib shows major LDL drop in Cleveland Clinic trial
Join the club for FREE to access the whole archive and other member benefits.
Combo of ezetimibe and obicetrapib shows major LDL drop in Cleveland Clinic trial
Cholesterol impairs heart cell energy; new antibody therapy restores mitochondrial function
Statins may help protect against dementia, regardless of cholesterol levels
Initial focus on lowering cholesterol by targeting NAD+ metabolism
Statins shown to benefit and save costs for people over 70
No resources found!
The real culprit is saturated fats, so your diet is still important